Ftse Mib
33.603,88
-2,20%
DAX
18.265,68
-2,03%
S&P 500
5.428,01
0,13%
NASDAQ
17.648,19
0,23%
Bitcoin
66.885,84
-2,00%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cellular Biomedicine Group Inc (CBMG) Cellular Biomedicine Group Inc (CBMG) Notizie

CBMG

Cellular Biomedicine (CBMG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CBMG
DataOraFonteTitoloSimboloCompagnia
03/03/202120:40Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CBMGCellular Biomedicine Group Inc
26/02/202112:14Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CBMGCellular Biomedicine Group Inc
22/02/202112:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202122:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121:11Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121:10Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121:07Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202121:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBMGCellular Biomedicine Group Inc
19/02/202120:55PR Newswire (US)Cellular Biomedicine Group, Inc. Announces Completion of MergerNASDAQ:CBMGCellular Biomedicine Group Inc
08/02/202122:19PR Newswire (US)Cellular Biomedicine Group, Inc. Stockholders Approve MergerNASDAQ:CBMGCellular Biomedicine Group Inc
01/02/202120:50Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CBMGCellular Biomedicine Group Inc
28/01/202122:30PR Newswire (US)Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed MergerNASDAQ:CBMGCellular Biomedicine Group Inc
26/01/202123:21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBMGCellular Biomedicine Group Inc
29/12/202022:11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CBMGCellular Biomedicine Group Inc
08/12/202012:42Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBMGCellular Biomedicine Group Inc
04/12/202013:35PR Newswire (US)Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual MeetingNASDAQ:CBMGCellular Biomedicine Group Inc
09/11/202023:24PR Newswire (US)Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business HighlightsNASDAQ:CBMGCellular Biomedicine Group Inc
09/11/202022:26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBMGCellular Biomedicine Group Inc
26/08/202015:00PR Newswire (US)Cellular Biomedicine Group to Present at Chinese Biopharmaceutical Association-USA Annual ConferenceNASDAQ:CBMGCellular Biomedicine Group Inc
14/08/202022:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBMGCellular Biomedicine Group Inc
14/08/202022:33Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBMGCellular Biomedicine Group Inc
13/08/202021:25Business WireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cellular Biomedicine Group, Inc.NASDAQ:CBMGCellular Biomedicine Group Inc
12/08/202022:30PR Newswire (US)Cellular Biomedicine Group (CBMG) Reports Q2, H1 2020 Financial Results and Business HighlightsNASDAQ:CBMGCellular Biomedicine Group Inc
12/08/202012:30PR Newswire (US)Cellular Biomedicine Group (CBMG) Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going PrivateNASDAQ:CBMGCellular Biomedicine Group Inc
10/08/202022:17Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:CBMGCellular Biomedicine Group Inc
13/07/202013:29PR Newswire (US)Cellular Biomedicine Group (CBMG) Hosts R&D Showcase and Provides Updates to Clinical ProgramsNASDAQ:CBMGCellular Biomedicine Group Inc
30/06/202022:15PR Newswire (US)Cellular Biomedicine Group (CBMG) to Host Investor R&D Showcase Highlighting Updates to Clinical ProgramsNASDAQ:CBMGCellular Biomedicine Group Inc
29/06/202014:55PR Newswire (US)Cellular Biomedicine Group (CBMG) Announces Results of 2020 Annual Meeting of StockholdersNASDAQ:CBMGCellular Biomedicine Group Inc
22/06/202015:00PR Newswire (US)Cellular Biomedicine Group (CBMG) Presents Poster of TCRs Targeting AFP-Positive Liver Cancer at AACR Annual MeetingNASDAQ:CBMGCellular Biomedicine Group Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CBMG

La tua Cronologia

LSE
RB36
Citi Fun 24
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network